254 related articles for article (PubMed ID: 31880829)
1. Propensity score-adjusted three-component mixture model for drug-drug interaction data mining in FDA Adverse Event Reporting System.
Wang X; Li L; Wang L; Feng W; Zhang P
Stat Med; 2020 Mar; 39(7):996-1010. PubMed ID: 31880829
[TBL] [Abstract][Full Text] [Related]
2. Three-Component Mixture Model-Based Adverse Drug Event Signal Detection for the Adverse Event Reporting System.
Zhang P; Li M; Chiang CW; Wang L; Xiang Y; Cheng L; Feng W; Schleyer TK; Quinney SK; Wu HY; Zeng D; Li L
CPT Pharmacometrics Syst Pharmacol; 2018 Aug; 7(8):499-506. PubMed ID: 30091855
[TBL] [Abstract][Full Text] [Related]
3. Mixture drug-count response model for the high-dimensional drug combinatory effect on myopathy.
Wang X; Zhang P; Chiang CW; Wu H; Shen L; Ning X; Zeng D; Wang L; Quinney SK; Feng W; Li L
Stat Med; 2018 Feb; 37(4):673-686. PubMed ID: 29171062
[TBL] [Abstract][Full Text] [Related]
4. Detecting high-quality signals of adverse drug-drug interactions from spontaneous reporting data.
Zhan C; Roughead E; Liu L; Pratt N; Li J
J Biomed Inform; 2020 Dec; 112():103603. PubMed ID: 33153975
[TBL] [Abstract][Full Text] [Related]
5. A pharmacovigilance study of pharmacokinetic drug interactions using a translational informatics discovery approach.
Wang L; Shendre A; Chiang CW; Cao W; Ning X; Zhang P; Zhang P; Li L
Br J Clin Pharmacol; 2022 Feb; 88(4):1471-1481. PubMed ID: 33543792
[TBL] [Abstract][Full Text] [Related]
6. Mining and visualizing high-order directional drug interaction effects using the FAERS database.
Yao X; Tsang T; Sun Q; Quinney S; Zhang P; Ning X; Li L; Shen L
BMC Med Inform Decis Mak; 2020 Mar; 20(Suppl 2):50. PubMed ID: 32183790
[TBL] [Abstract][Full Text] [Related]
7. Discovering clinical drug-drug interactions with known pharmacokinetics mechanisms using spontaneous reporting systems and electronic health records.
Jeong E; Su Y; Li L; Chen Y
J Biomed Inform; 2024 May; 153():104639. PubMed ID: 38583580
[TBL] [Abstract][Full Text] [Related]
8. Mining association patterns of drug-interactions using post marketing FDA's spontaneous reporting data.
Ibrahim H; Saad A; Abdo A; Sharaf Eldin A
J Biomed Inform; 2016 Apr; 60():294-308. PubMed ID: 26903152
[TBL] [Abstract][Full Text] [Related]
9. Complementing the US Food and Drug Administration Adverse Event Reporting System With Adverse Drug Reaction Reporting From Social Media: Comparative Analysis.
Zhou Z; Hultgren KE
JMIR Public Health Surveill; 2020 Sep; 6(3):e19266. PubMed ID: 32996889
[TBL] [Abstract][Full Text] [Related]
10. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.
Leone R; Magro L; Moretti U; Cutroneo P; Moschini M; Motola D; Tuccori M; Conforti A
Drug Saf; 2010 Aug; 33(8):667-75. PubMed ID: 20635825
[TBL] [Abstract][Full Text] [Related]
11. Automatic signal extraction, prioritizing and filtering approaches in detecting post-marketing cardiovascular events associated with targeted cancer drugs from the FDA Adverse Event Reporting System (FAERS).
Xu R; Wang Q
J Biomed Inform; 2014 Feb; 47():171-7. PubMed ID: 24177320
[TBL] [Abstract][Full Text] [Related]
12. Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database.
Subeesh V; Maheswari E; Singh H; Beulah TE; Swaroop AM
Curr Drug Saf; 2019; 14(1):21-26. PubMed ID: 30362421
[TBL] [Abstract][Full Text] [Related]
13. Mining Directional Drug Interaction Effects on Myopathy Using the FAERS Database.
Chasioti D; Yao X; Zhang P; Lerner S; Quinney SK; Ning X; Li L; Shen L
IEEE J Biomed Health Inform; 2019 Sep; 23(5):2156-2163. PubMed ID: 30296244
[TBL] [Abstract][Full Text] [Related]
14. Profiling cumulative proportional reporting ratios of drug-induced liver injury in the FDA Adverse Event Reporting System (FAERS) database.
Brinker AD; Lyndly J; Tonning J; Moeny D; Levine JG; Avigan MI
Drug Saf; 2013 Dec; 36(12):1169-78. PubMed ID: 24178291
[TBL] [Abstract][Full Text] [Related]
15. Mining clinical text for signals of adverse drug-drug interactions.
Iyer SV; Harpaz R; LePendu P; Bauer-Mehren A; Shah NH
J Am Med Inform Assoc; 2014; 21(2):353-62. PubMed ID: 24158091
[TBL] [Abstract][Full Text] [Related]
16. Statistical methods for exploring spontaneous adverse event reporting databases for drug-host factor interactions.
Lu Z; Suzuki A; Wang D
BMC Med Res Methodol; 2023 Mar; 23(1):71. PubMed ID: 36973693
[TBL] [Abstract][Full Text] [Related]
17. Significance of data mining in routine signal detection: Analysis based on the safety signals identified by the FDA.
Fukazawa C; Hinomura Y; Kaneko M; Narukawa M
Pharmacoepidemiol Drug Saf; 2018 Dec; 27(12):1402-1408. PubMed ID: 30324671
[TBL] [Abstract][Full Text] [Related]
18. Empirical estimation of under-reporting in the U.S. Food and Drug Administration Adverse Event Reporting System (FAERS).
Alatawi YM; Hansen RA
Expert Opin Drug Saf; 2017 Jul; 16(7):761-767. PubMed ID: 28447485
[TBL] [Abstract][Full Text] [Related]
19. Data mining for signal detection of adverse events for taxanes based on the food and drug administration adverse drug events reporting system database.
Wang LY; Liao LF; Lei CL; Wu Q; Guo YJ; Li Y
Expert Opin Drug Saf; 2023; 22(9):833-839. PubMed ID: 37055919
[TBL] [Abstract][Full Text] [Related]
20. Validation of New Signal Detection Methods for Web Query Log Data Compared to Signal Detection Algorithms Used With FAERS.
Colilla S; Tov EY; Zhang L; Kurzinger ML; Tcherny-Lessenot S; Penfornis C; Jen S; Gonzalez DS; Caubel P; Welsh S; Juhaeri J
Drug Saf; 2017 May; 40(5):399-408. PubMed ID: 28155198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
